SCLX

Conviction 26HealthcareScan · Thu, Jun 25, 2026

SCLX$7.03+2.48%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 124.93K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Scilex Holding CoBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.scilexholding.com ↗

Price7.03

Change+2.48%

Gap-1.60%

Rel volume4.45×

Avg volume129.8K

Avg $ vol973.07K

SMA 207.45

SMA 507.41

SMA 20012.47

Price vs 50-5.15%

Price vs 200-43.64%

MA stackbearish

50/200 cross—

Supertrendup · 5.78

RSI (14)48

MACD hist-0.07

MACD crossbear · 6d

Stoch %K / %D42 / 40

ADX (14)16

+DI / −DI25 / 22

RSI divergence—

MACD divergence—

ATR %+13.42%

ADR %12.17%

52w high30.00

52w low5.30

From 52w high-76.57%

Above 52w low+32.64%

New 52w highNo

SqueezeOff

Bollinger width41.32%

%B0.36

Donchian pos37.37%

Donchian high9.75

Donchian low5.41

AVWAP (52w high)14.52

vs AVWAP high-51.59%

AVWAP (52w low)7.68

vs AVWAP low-8.48%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d4.45×

Avg vol (14d)124.93K

Avg vol (20d)129.8K

Avg $ vol (20d)973.07K

Market cap59.69M

RS 3m (vs SPY)-8.47%

RS 6m (vs SPY)-59.93%

RS line new highNo

Trend template1/8

Technical rank25.3

1 week+1.30%

1 month+9.76%

3 months+4.61%

6 months-50.74%

1 year+27.82%

YTD-46.29%

P/E-0.16

P/B-0.24

P/S1.97

P/FCF16.21

EPS-36.48

Div yield14.49%

ROE150.09%

ROA-127.39%

Debt/Eq-0.32

Current0.08

EV/EBITDA-0.40

Gross margin415.83%

Net margin—

Rev growth-46.54%

EPS growth-413.76%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value137.13M

Revenue8.61M

Net income-45.65M

Gross profit25.7M

Free cash flow3.68M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out8.49M

Employees34

ListedFri, Nov 11, 2022

Free float6.29M

Float %74.1%

Short interest229.01K

Days to cover1.8d

Short volume66.6%

Squeeze score49 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction26 / 100

Pattern quality—

Tech rank25.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.04

Support5.49

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCLX

All disclosures →

No recent disclosed trades by Congress in SCLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCLX · 2 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Ji Henry Exec Chair, CEO and President · Warrant (right to buy) · 2026-04-17	Sell	650K	$100K	2026-04-17	2026-04-20
Ma Stephen Hoi CFO, COO and Secretary · Warrant (right to buy) · 2026-04-17	Buy	650K	$100K	2026-04-17	2026-04-20
Ji Henry Exec Chair, CEO and President · Warrant (right to buy) · 2026-04-16	Buy	3.25M	$500K	2026-04-16	2026-04-20

SEC filings

EDGAR filings in SCLX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.